\babel@toc {english}{}\relax 
\babel@toc {ngerman}{}\relax 
\babel@toc {english}{}\relax 
\babel@toc {english}{}\relax 
\contentsline {chapter}{Declaration}{iv}{chapter*.1}%
\babel@toc {english}{}\relax 
\contentsline {chapter}{Abstract}{vii}{chapter*.3}%
\contentsline {chapter}{Kurzfassung}{viii}{chapter*.4}%
\babel@toc {ngerman}{}\relax 
\babel@toc {english}{}\relax 
\contentsline {chapter}{Acronyms}{ix}{section*.5}%
\contentsline {chapter}{\numberline {1}Introduction}{1}{chapter.1}%
\contentsline {section}{\numberline {1.1}Machine Learning in drug design and activity prediction}{3}{section.1.1}%
\contentsline {section}{\numberline {1.2}Goals}{4}{section.1.2}%
\contentsline {chapter}{\numberline {2}Methods}{5}{chapter.2}%
\contentsline {section}{\numberline {2.1}Data description}{5}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}Proteins}{5}{subsection.2.1.1}%
\contentsline {subsection}{\numberline {2.1.2}Interactions}{6}{subsection.2.1.2}%
\contentsline {subsection}{\numberline {2.1.3}Data origin and structure}{7}{subsection.2.1.3}%
\contentsline {section}{\numberline {2.2}Data partitioning}{8}{section.2.2}%
\contentsline {section}{\numberline {2.3}Machine-Learning approaches}{8}{section.2.3}%
\contentsline {subsection}{\numberline {2.3.1}Neural networks}{8}{subsection.2.3.1}%
\contentsline {subsection}{\numberline {2.3.2}K nearest neighbor}{10}{subsection.2.3.2}%
\contentsline {subsection}{\numberline {2.3.3}Random forest}{10}{subsection.2.3.3}%
\contentsline {section}{\numberline {2.4}Feature engineering}{11}{section.2.4}%
\contentsline {subsection}{\numberline {2.4.1}Feature engineering using random forest}{11}{subsection.2.4.1}%
\contentsline {subsection}{\numberline {2.4.2}Physical properties}{12}{subsection.2.4.2}%
\contentsline {subsection}{\numberline {2.4.3}\acrfull *[]{pca}}{13}{subsection.2.4.3}%
\contentsline {subsection}{\numberline {2.4.4}Balancing classes}{13}{subsection.2.4.4}%
\contentsline {section}{\numberline {2.5}Quality metrics}{14}{section.2.5}%
\contentsline {subsection}{\numberline {2.5.1}Terminology}{14}{subsection.2.5.1}%
\contentsline {subsection}{\numberline {2.5.2}Visual metrics}{14}{subsection.2.5.2}%
\contentsline {subsection}{\numberline {2.5.3}Accuracy}{14}{subsection.2.5.3}%
\contentsline {subsection}{\numberline {2.5.4}False positive Rate}{14}{subsection.2.5.4}%
\contentsline {subsection}{\numberline {2.5.5}Area under the curve}{15}{subsection.2.5.5}%
\contentsline {subsection}{\numberline {2.5.6}Yield of Actives}{15}{subsection.2.5.6}%
\contentsline {subsection}{\numberline {2.5.7}Enrichment Factor}{15}{subsection.2.5.7}%
\contentsline {subsection}{\numberline {2.5.8}Relative Enrichment Factor}{15}{subsection.2.5.8}%
\contentsline {chapter}{\numberline {3}Results}{16}{chapter.3}%
\contentsline {section}{\numberline {3.1}Feature Engineering Results for \acrshort *[]{ache}}{16}{section.3.1}%
\contentsline {section}{\numberline {3.2}Performance per Protein-Complex}{18}{section.3.2}%
\contentsline {subsection}{\numberline {3.2.1}Acetylcholinesterase}{19}{subsection.3.2.1}%
\contentsline {subsection}{\numberline {3.2.2}Cyclooxygenase 1}{21}{subsection.3.2.2}%
\contentsline {subsection}{\numberline {3.2.3}Dipeptidyl peptidase IV}{24}{subsection.3.2.3}%
\contentsline {subsection}{\numberline {3.2.4}Monoamine oxidase B}{27}{subsection.3.2.4}%
\contentsline {subsection}{\numberline {3.2.5}Soluble epoxide hydrolase}{29}{subsection.3.2.5}%
\contentsline {section}{\numberline {3.3}Performance Overview -- Comparing ML-approaches â†’ maybe use median instead of avg ask MICHA}{32}{section.3.3}%
\contentsline {chapter}{\numberline {4}Discussion}{33}{chapter.4}%
\contentsline {section}{\numberline {4.1}Conclusion}{33}{section.4.1}%
\contentsline {section}{\numberline {4.2}Improvements and outlook}{34}{section.4.2}%
\contentsline {chapter}{References}{35}{appendix*.40}%
\contentsline {section}{Literature}{35}{section*.41}%
